journal article·2024-11-27Open access

Cellular Nanoparticles Treat Coronavirus Infection in Vivo

Yiyan Yu, Daniela Silva-Ayala, Zhidong Zhou, Yifei Peng, Ronnie H. Fang, Weiwei Gao, Anthony Griffiths, Liangfang Zhang

Nano Letters· Volume 24· Issue 47

Abstract

High Resolution Image Download MS PowerPoint Slide Cellular nanoparticles (CNPs), which refer to nanoparticles coated with natural cell membranes, are promising for neutralizing pathological agents. Here, we use CNPs as a medical countermeasure against the infection of SARS-CoV-2 variants in an animal model. CNPs comprise polymeric cores coated with the plasma membranes of human macrophages. The resulting nanoparticles (MΦ-NPs) act as host cell decoys to intercept SARS-CoV-2 and block its cellular entry, thus inhibiting subsequent viral infection. Our findings indicate that MΦ-NPs bind to the spike proteins of SARS-CoV-2 variants in a dose-dependent manner and inhibit the infectivity of live viruses. In hamsters infected with SARS-CoV-2 variants, MΦ-NPs significantly reduce the viral burden in the lungs, demonstrating their effectiveness in inhibiting viral infectivity in vivo . Furthermore, MΦ-NPs are primarily taken up by alveolar macrophages without inducing noticeable adverse effects. Given the crucial role of macrophages in viral infections, MΦ-NPs present a promising approach to combating emerging viral threats.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · SARS-CoV-2 and COVID-19 Research · Long-Term Effects of COVID-19

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Aiiso Yufeng Li Family Department of Chemical and Nano Engineering, Shu and K.C. Chien and Peter Farrell Collaboratory, University of California San Diego, La Jolla, California 92093, United States

Department of Microbiology and National Emerging Infectious Diseases Laboratories, School of Medicine, Boston University, Boston, Massachusetts 02115, United States

Laboratory for Infectious Disease Research and Department of Molecular Microbiology and Immunology, School of Medicine, University of Missouri, Columbia, Missouri 65211, United States

Funding

Defense Threat Reduction Agency

References (38)

Show source-provided references
1. 10.1016/j.ijsu.2020.02.03410.1016/j.ijsu.2020.02.034 ↗
2. 10.1016/S0140-6736(20)30185-910.1016/S0140-6736(20)30185-9 ↗
3. 10.1038/s41573-023-00672-y10.1038/s41573-023-00672-y ↗
4. 10.1038/s41581-022-00642-410.1038/s41581-022-00642-4 ↗
5. 10.1038/s41565-022-01174-510.1038/s41565-022-01174-5 ↗
6. 10.1016/j.cossms.2021.10096410.1016/j.cossms.2021.100964 ↗
7. 10.1001/jama.2021.319910.1001/jama.2021.3199 ↗
8. 10.1056/NEJMsr210528010.1056/NEJMsr2105280 ↗
9. 10.1016/j.ejmech.2022.11412110.1016/j.ejmech.2022.114121 ↗
10. 10.1021/acs.chemrev.3c0070510.1021/acs.chemrev.3c00705 ↗
11. 10.1007/s12026-023-09416-x10.1007/s12026-023-09416-x ↗
12. 10.7150/thno.4669110.7150/thno.46691 ↗
13. 10.1021/acs.nanolett.1c0068010.1021/acs.nanolett.1c00680 ↗
14. 10.1038/s41551-022-00902-510.1038/s41551-022-00902-5 ↗
15. 10.1073/pnas.201435211710.1073/pnas.2014352117 ↗
16. 10.1021/jacs.1c0779810.1021/jacs.1c07798 ↗
17. 10.1021/acs.nanolett.1c0226610.1021/acs.nanolett.1c02266 ↗
18. 10.1016/j.bbrc.2020.09.01810.1016/j.bbrc.2020.09.018 ↗
19. 10.1002/adma.20170675910.1002/adma.201706759 ↗
20. 10.1002/adma.20210771910.1002/adma.202107719 ↗
21. 10.1038/s41590-021-01122-w10.1038/s41590-021-01122-w ↗
22. 10.3389/fimmu.2020.0131210.3389/fimmu.2020.01312 ↗
23. 10.1016/j.medj.2023.08.00110.1016/j.medj.2023.08.001 ↗
24. 10.1002/adma.20180223310.1002/adma.201802233 ↗
25. 10.1128/mBio.00903-2010.1128/mBio.00903-20 ↗
26. 10.1021/acs.nanolett.0c0227810.1021/acs.nanolett.0c02278 ↗
27. 10.1038/s41467-024-45274-310.1038/s41467-024-45274-3 ↗
28. 10.1093/cid/ciac27910.1093/cid/ciac279 ↗
29. 10.1073/pnas.110663410810.1073/pnas.1106634108 ↗
30. 10.3390/cells1006143410.3390/cells10061434 ↗
31. 10.1038/s41586-021-03925-110.1038/s41586-021-03925-1 ↗
32. 10.1073/pnas.200979911710.1073/pnas.2009799117 ↗
33. 10.1126/science.abc752010.1126/science.abc7520 ↗
34. 10.1126/scisignal.abq136610.1126/scisignal.abq1366 ↗
35. 10.1038/s41421-024-00734-410.1038/s41421-024-00734-4 ↗
36. 10.1038/s41551-022-00902-510.1038/s41551-022-00902-5 ↗
37. 10.1016/j.nantod.2021.10128010.1016/j.nantod.2021.101280 ↗
38. 10.1021/acsnano.1c1113210.1021/acsnano.1c11132 ↗